Articles with public access mandates - Pawel KalinskiLearn more
Not available anywhere: 3
PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
N Obermajer, JL Wong, RP Edwards, K Odunsi, K Moysich, P Kalinski
Immunological investigations 41 (6-7), 635-657, 2012
Mandates: US National Institutes of Health
Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+ T cells
R Muthuswamy, JM Corman, K Dahl, GS Chatta, P Kalinski
The prostate 76 (12), 1095-1105, 2016
Mandates: US National Institutes of Health
Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues
R Muthuswamy, NJ Okada, FJ Jenkins, K McGuire, PF McAuliffe, HJ Zeh, ...
Brain, behavior, and immunity 62, 78-86, 2017
Mandates: US National Institutes of Health
Available somewhere: 99
Regulation of immune responses by prostaglandin E2
P Kalinski
The Journal of Immunology 188 (1), 21-28, 2012
Mandates: US National Institutes of Health
Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic …
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ...
Journal of clinical oncology 29 (3), 330-336, 2011
Mandates: US National Institutes of Health
Immunotherapy of cancer in 2012
JM Kirkwood, LH Butterfield, AA Tarhini, H Zarour, P Kalinski, S Ferrone
CA: a cancer journal for clinicians 62 (5), 309-335, 2012
Mandates: US National Institutes of Health
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
Mandates: US National Institutes of Health, National Health and Medical Research …
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
N Obermajer, R Muthuswamy, J Lesnock, RP Edwards, P Kalinski
Blood, The Journal of the American Society of Hematology 118 (20), 5498-5505, 2011
Mandates: US National Institutes of Health
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
N Obermajer, R Muthuswamy, K Odunsi, RP Edwards, P Kalinski
Cancer research 71 (24), 7463-7470, 2011
Mandates: US National Institutes of Health
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Z Liu, R Ravindranathan, P Kalinski, ZS Guo, DL Bartlett
Nature communications 8 (1), 14754, 2017
Mandates: US National Institutes of Health
Zinc in innate and adaptive tumor immunity
E John, TC Laskow, WJ Buchser, BR Pitt, PH Basse, LH Butterfield, ...
Journal of translational medicine 8, 1-16, 2010
Mandates: US National Institutes of Health
IL‐23‐dependent IL‐17 drives Th1‐cell responses following Mycobacterium bovis BCG vaccination
R Gopal, Y Lin, N Obermajer, S Slight, N Nuthalapati, M Ahmed, ...
European journal of immunology 42 (2), 364-373, 2012
Mandates: US National Institutes of Health
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation
R Muthuswamy, J Urban, JJ Lee, TA Reinhart, D Bartlett, P Kalinski
Cancer research 68 (14), 5972-5978, 2008
Mandates: US National Institutes of Health
Defining the critical hurdles in cancer immunotherapy
BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ...
Journal of translational medicine 9, 1-15, 2011
Mandates: US National Institutes of Health
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity
HJ Zeh, S Downs-Canner, JA McCart, ZS Guo, UNM Rao, L Ramalingam, ...
Molecular Therapy 23 (1), 202-214, 2015
Mandates: US National Institutes of Health
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
A Alam, E Levanduski, P Denz, HS Villavicencio, M Bhatta, L Alhorebi, ...
Cancer cell 40 (2), 153-167. e11, 2022
Mandates: US National Institutes of Health
Consensus nomenclature for CD8+ T cell phenotypes in cancer
L Apetoh, MJ Smyth, CG Drake, JP Abastado, RN Apte, M Ayyoub, ...
Oncoimmunology 4 (4), e998538, 2015
Mandates: US National Institutes of Health, National Health and Medical Research …
PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells
R Muthuswamy, J Mueller-Berghaus, U Haberkorn, TA Reinhart, ...
Blood, The Journal of the American Society of Hematology 116 (9), 1454-1459, 2010
Mandates: US National Institutes of Health
IL-18–Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
JL Wong, E Berk, RP Edwards, P Kalinski
Cancer research 73 (15), 4653-4662, 2013
Mandates: US National Institutes of Health
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer
J Li, M O'malley, J Urban, P Sampath, ZS Guo, P Kalinski, SH Thorne, ...
Molecular Therapy 19 (4), 650-657, 2011
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program